miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis.
Authors: Garrido-Torres, Nathalia (AUTHOR), Guzmán-Torres, Karem (AUTHOR), García-Cerro, Susana (AUTHOR), Pinilla Bermúdez, Gladys (AUTHOR), Cruz-Baquero, Claudia (AUTHOR), Ochoa, Hansel (AUTHOR), García-González, Diego (AUTHOR), Canal-Rivero, Manuel (AUTHOR), Crespo-Facorro, Benedicto (AUTHOR), Ruiz-Veguilla, Miguel (AUTHOR)
Source: European Child & Adolescent Psychiatry. Sep2024, Vol. 33 Issue 9, p2957-2990. 34p.
Subjects: Diagnosis of autism, Saliva analysis, Genetics of autism, MicroRNA, Meta-analysis, Gene expression, Pediatrics, Systematic reviews, MEDLINE, Social skills, Asperger's syndrome, Online information services, Interpersonal relations, Biomarkers
Geographic Terms: Spain
Abstract: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex clinical manifestations that arise between 18 and 36 months of age. Social interaction deficiencies, a restricted range of interests, and repetitive stereotyped behaviors are characteristics which are sometimes difficult to detect early. Several studies show that microRNAs (miRs/miRNAs) are strongly implicated in the development of the disorder and affect the expression of genes related to different neurological pathways involved in ASD. The present systematic review and meta-analysis addresses the current status of miRNA studies in different body fluids and the most frequently dysregulated miRNAs in patients with ASD. We used a combined approach to summarize miRNA fold changes in different studies using the mean values. In addition, we summarized p values for differential miRNA expression using the Fisher method. Our literature search yielded a total of 133 relevant articles, 27 of which were selected for qualitative analysis based on the inclusion and exclusion criteria, and 16 studies evaluating miRNAs whose data were completely reported were ultimately included in the meta-analysis. The most frequently dysregulated miRNAs across the analyzed studies were miR-451a, miR-144-3p, miR-23b, miR-106b, miR150-5p, miR320a, miR92a-2-5p, and miR486-3p. Among the most dysregulated miRNAs in individuals with ASD, miR-451a is the most relevant to clinical practice and is associated with impaired social interaction. Other miRNAs, including miR19a-3p, miR-494, miR-142-3p, miR-3687, and miR-27a-3p, are differentially expressed in various tissues and body fluids of patients with ASD. Therefore, all these miRNAs can be considered candidates for ASD biomarkers. Saliva may be the optimal biological fluid for miRNA measurements, because it is easy to collect from children compared to other biological fluids. [ABSTRACT FROM AUTHOR]
Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first